Clinical trial
S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic…
NCT00006020 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00006020 |
|---|---|
| Title | S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia |
| Official title | A Phase II Trial of 506U78 (IND 52611) in Patients With Relapsed or Refractory Non T-cell Acute Lymphoblastic Leukemia (ALL) |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Drug |
| Interventions | nelarabine |
| Enrollment | 35 |
| Start date | Jul 1, 2000 |
| Primary completion | Jun 1, 2004 |
| Completion | Jul 1, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | Mar 6, 2015 |
| Countries | United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: